Recurrent uveitis under golimumab treatment in a patient diagnosed with axial spondyloarthritis: Is it a paradoxical effect?
Monoclonal antibodies
panuveitis
spondylarthropathies
tumor necrosis factor-alpha
Journal
Turkish journal of physical medicine and rehabilitation
ISSN: 2587-1250
Titre abrégé: Turk J Phys Med Rehabil
Pays: Turkey
ID NLM: 101719024
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
received:
05
01
2018
accepted:
01
03
2018
entrez:
28
8
2019
pubmed:
28
8
2019
medline:
28
8
2019
Statut:
epublish
Résumé
Anti-tumor necrosis factor drugs are highly effective in the treatment of spondyloarthropathies. In recent years, there have been reports of paradoxical effects with the use of these drugs. Herein, we report the first case of axial spondyloarthropathy in whom recurrent attacks of panuveitis paradoxically developed under golimumab treatment in the light of literature data.
Identifiants
pubmed: 31453561
doi: 10.5606/tftrd.2019.2596
pmc: PMC6706823
doi:
Types de publication
Case Reports
Langues
eng
Pagination
191-193Déclaration de conflit d'intérêts
Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.
Références
Ann Rheum Dis. 2006 Dec;65(12):1631-4
pubmed: 16901960
Arthritis Rheum. 2007 Oct;56(10):3248-52
pubmed: 17907169
Ann Rheum Dis. 2008 Jul;67(7):955-9
pubmed: 17962239
Ann Rheum Dis. 2009 Jun;68(6):777-83
pubmed: 19297344
Rheumatology (Oxford). 2009 Jul;48(7):761-4
pubmed: 19395543
Core Evid. 2010 Jun 15;4:159-70
pubmed: 20694072
Semin Arthritis Rheum. 2011 Dec;41(3):503-10
pubmed: 21862108
Clin Exp Ophthalmol. 2014 May-Jun;42(4):392-5
pubmed: 24024585
RMD Open. 2016 Jul 15;2(2):e000239
pubmed: 27493788